Modulation of atherosclerosis in mice by Toll-like receptor 2

Journal of Clinical Investigation

Volumn 115, Issue 11, 2005, Pages 3149-3156

  Mullick, Adam E ^a   Tobias, Peter S ^a   Curtiss, Linda K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PAM3CSK4; TOLL LIKE RECEPTOR 1 AGONIST; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CONTROLLED STUDY; INFLAMMATION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; SIGNAL TRANSDUCTION;

ANIMALS; AORTA; ATHEROSCLEROSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHOLESTEROL; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 2;

EID: 27644568878     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25482     Document Type: Article

References (40)

1. Murray, C.J., et al. 2003. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 361:717-725.
2. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420:868-874.
3. Kol, A., and Libby, P. 1998. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc. Med. 8:191-199.
4. Mendall, M.A., et al. 1995. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J. Infect. 30:121-128.
5. Kalayoglu, M.V., Libby, P., and Byrne, G.I. 2002. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 288:2724-2731.
6. Gibson, F.C., 3rd, et al. 2004. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 109:2801-2806.
7. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
8. Beutler, B. 2004. Inferences, questions and possibilities in Toll-Like receptor signalling. Nature. 430:257-263.
9. Tobias, P., and Curtiss, L.K. 2005. Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J. Lipid Res. 46:404-411.
10. Saikku, P., et al. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:983-986.
11. Desvarieux, M., et al. 2005. Periodontal microbiota and carotid intima-media thickness: the Oral infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 111:576-582.
12. Arcari, C.M., Gaydos, C.A., Nieto, F.J., Krauss, M., and Nelson, K.E. 2005. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement. Clin. Infect. Dis. 40:1123-1130.
13. Kuo, C.C., et al. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
14. Oshima, T., et al. 2005. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J. Am. Coll. Cardiol. 45:1219-1222.
15. Xu, X.H., et al. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation. 104:3103-3108.
16. Edfeldt, K., Swedenborg, J., Hansson, G.K., and Yan, Z.Q. 2002. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 105:1158-1161.
17. Hollestelle, S.C., et al. 2004. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation. 109:393-398.
18. Michelsen, K.S., et al. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 101:10679-10684.
19. Bjorkbacka, H., et al. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10:416-421.
20. Schoneveld, A.H., et al. 2005. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc. Res. 66:162-169.
21. Michelsen, K.S., Doherty, T.M., Shah, P.K., and Arditi, M. 2004. Role of Toll-like receptors in atherosclerosis. Circ. Res. 95:e96-e97.
22. Akira, S., and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
23. Ozinsky, A., et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 97:13766-13771.
24. Takeuchi, O., et al. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14.
25. Takeuchi, O., et al. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-940.
26. Hoebe, K., et al. 2005. CD36 is a sensor of diacylglycerides. Nature. 433:523-527.
27. Dunzendorfer, S., Lee, H.K., and Tobias, P.S. 2004. Flow-dependent regulation ofendothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ. Res. 95:684-691.
28. Boisvert, W.A., Spangenberg, J., and Curtiss, L.K. 1997. Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. Arteriosckr. Thromb. Vasc. Biol. 17:340-347.
29. Zhang, F.X., et al. 1999. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611-7614.
30. Faure, E., et al. 2001. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J. Immunol. 166:2018-2024.
31. Faure, E., et al. 2000. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058-11063.
32. Bulut, Y., Faure, E., Thomas, L., Equils, O., and Arditi, M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:987-994.
33. Laman, J.D., Schoneveld, A.H., Moll, F.L., van Meurs, M., and Pasterkamp, G. 2002. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 90:119-123.
34. O'Neill, L.A., and Greene, C. 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63:650-657.
35. Ostos, M.A., Recalde, D., Zakin, M.M., and Scott-Algara, D. 2002. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett. 519:23-29.
36. Lehr, H.A., et al. 2001. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 104:914-920.
37. Schiller, N.K., Kubo, N., Boisvert, W.A., and Curtiss, L.K. 2001. Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arteriosder. Thromb. Vasc. Biol. 21:1674-1680.
38. Boisvert, W.A., Spangenberg, J., and Curtiss, L.K. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96:1118-1124.
39. Mori, N., Horie, Y., Nimura, Y., Wolf, R., and Granger, D.N. 2000. Hepatic microvascular responses to ischemia-reperfusion in low-density lipoprotein receptor knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G1257-G1264,
40. Schiller, N.K., Black, A.S., Bradshaw, G.P., Bonnet, D.J., and Curtiss, L.K. 2004. Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. J. Lipid Res. 45:1398-1409.